These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Clinical course and endocrine dysfunction in X-linked adrenoleukodystrophy: A case series. Matos T; Costa C; Araújo AN; do Vale S Endocrinol Diabetes Nutr (Engl Ed); 2023; 70(6):421-428. PubMed ID: 37356877 [TBL] [Abstract][Full Text] [Related]
26. Variability of endocrinological dysfunction in 55 patients with X-linked adrenoleucodystrophy: clinical, laboratory and genetic findings. Korenke GC; Roth C; Krasemann E; Hüfner M; Hunneman DH; Hanefeld F Eur J Endocrinol; 1997 Jul; 137(1):40-7. PubMed ID: 9242200 [TBL] [Abstract][Full Text] [Related]
27. The cystathionine beta-synthase variant c.844_845ins68 protects against CNS demyelination in X-linked adrenoleukodystrophy. Linnebank M; Semmler A; Kleijer WJ; van der Sterre ML; Gärtner J; Fliessbach K; Sokolowski P; Köhler W; Schlegel U; Klockgether T; Wanders RJ; Schmidt S; Wüllner U; Kemp S Hum Mutat; 2006 Oct; 27(10):1063-4. PubMed ID: 16941496 [TBL] [Abstract][Full Text] [Related]
28. Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients. Jang J; Kang HC; Kim HS; Kim JY; Huh YJ; Kim DS; Yoo JE; Lee JA; Lim B; Lee J; Yoon TM; Park IH; Hwang DY; Daley GQ; Kim DW Ann Neurol; 2011 Sep; 70(3):402-9. PubMed ID: 21721033 [TBL] [Abstract][Full Text] [Related]
29. [Screening for carrier and prenatal diagnosis of X-linked adrenoleukodystrophy]. Wang AH; Bao XH; Xiong H; Pan H; Wu Y; Zhang YH; Shi CY; Qin J; Wu XR Zhonghua Er Ke Za Zhi; 2005 May; 43(5):345-9. PubMed ID: 15924749 [TBL] [Abstract][Full Text] [Related]
30. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. van Geel BM; Bezman L; Loes DJ; Moser HW; Raymond GV Ann Neurol; 2001 Feb; 49(2):186-94. PubMed ID: 11220738 [TBL] [Abstract][Full Text] [Related]
31. Mutations, clinical findings and survival estimates in South American patients with X-linked adrenoleukodystrophy. Pereira Fdos S; Matte U; Habekost CT; de Castilhos RM; El Husny AS; Lourenço CM; Vianna-Morgante AM; Giuliani L; Galera MF; Honjo R; Kim CA; Politei J; Vargas CR; Jardim LB PLoS One; 2012; 7(3):e34195. PubMed ID: 22479560 [TBL] [Abstract][Full Text] [Related]
32. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Pujol A; Hindelang C; Callizot N; Bartsch U; Schachner M; Mandel JL Hum Mol Genet; 2002 Mar; 11(5):499-505. PubMed ID: 11875044 [TBL] [Abstract][Full Text] [Related]
33. X-linked adrenoleukodystrophy: phenotype distribution and expression of ALDP in Spanish kindreds. Ruiz M; Coll MJ; Pàmpols T; Girós M Am J Med Genet; 1998 Apr; 76(5):424-7. PubMed ID: 9556303 [TBL] [Abstract][Full Text] [Related]
35. Clinical, neuroimaging, biochemical, and genetic features in six Chinese patients with Adrenomyeloneuropathy. Li J; Wang H; He Z; Wang X; Tang J; Huang D BMC Neurol; 2019 Sep; 19(1):227. PubMed ID: 31526374 [TBL] [Abstract][Full Text] [Related]
36. Spastic paraplegia as the predominant phenotype in a cohort of Chinese patients with adrenoleukodystrophy. Luo WJ; Wei Q; Dong HL; Yan YT; Chen MJ; Li HF Mol Genet Genomic Med; 2020 Jan; 8(1):e1065. PubMed ID: 31777199 [TBL] [Abstract][Full Text] [Related]
37. Phenotypic variability in a Tunisian family with X-linked adrenoleukodystrophy caused by the p.Gln316Pro novel mutation. Kallabi F; Ellouz E; Tabebi M; Ben Salah G; Kaabechi N; Keskes L; Triki C; Kamoun H Clin Chim Acta; 2016 Jan; 453():141-6. PubMed ID: 26686776 [TBL] [Abstract][Full Text] [Related]